Related Experiment Videos
Hyaluronidase increases electrogene transfer efficiency in skeletal muscle
Carmela Mennuni1, Francesco Calvaruso, Immacolata Zampaglione
1Istituto di Ricerche di Biologia Molecolare P. Angeletti, 00040 Pomezia, Italy.
Human Gene Therapy
|February 28, 2002
Summary
Preinjecting hyaluronidase (HYAse) before electrogene transfer (EGT) significantly enhances gene expression in skeletal muscle. This method shows promise for treating muscle disorders and achieving therapeutic protein levels.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Electrogene transfer (EGT) is a key method for delivering plasmid DNA to skeletal muscle for therapeutic protein production.
- Optimizing gene transfer efficiency is crucial for the clinical success of muscle-targeted gene therapy.
Purpose of the Study:
- To investigate the impact of hyaluronidase (HYAse) pretreatment on the efficiency of skeletal muscle electrogene transfer.
- To evaluate the potential of combining HYAse with EGT for enhanced therapeutic gene expression.
Main Methods:
- Plasmid DNA constructs (encoding EPO, SeAP, luciferase, beta-galactosidase) were electroinjected into skeletal muscles of mice and rabbits.
- Muscles were pretreated with hyaluronidase (HYAse) at varying time points before EGT.
- Gene expression levels and tissue distribution were analyzed using various assays and histological examination.
Main Results:
- HYAse pretreatment significantly increased gene expression, with fold-increases ranging from 5-fold (EPO in mice) to 24-fold (luciferase in rabbits).
- HYAse expanded the tissue area demonstrating gene expression.
- Histological analysis confirmed no irreversible tissue damage after HYAse pretreatment and EGT.
Conclusions:
- Pretreatment with hyaluronidase is a safe and effective strategy to enhance gene transfer efficiency in skeletal muscle via EGT.
- This combined approach offers a promising method for achieving therapeutic levels of gene expression for muscle disorders.